Microbiota and Mucosal Infections
16th Lorne Infection and Immunity 2026
Days
Wednesday, 18th February
Thursday, 19th February
Friday, 20th February
Tracks
Adaptive Immunity
Advances in Treatment for Infectious Diseases
Emerging Infectious Disease Threats (and/or Antimicrobial Resistance)
Host-Pathogen Interactions
Innate Immunity
Microbiota and Mucosal Infections
Molecular Basis of Infectious Diseases
Search
Speakers
Session 6: Mucosal Infections and Microbiota
11:00AM - 1:00PM
Thursday, 19th February
Heritage Dining Room
Chair: Matthew Payne
Increased IL17 Pathway Activation and Microbiome Diversity in Endometrial Tissue from Women who Fail Assisted Reproductive Technology (ART)
-
Cliona O'Farrelly
Microbiota-derived butyrate promotes CD8
+
T cell immunity against melanoma
-
Annabell Bachem
Investigating the immune response to Uropathogenic
Escheriachia coli
to identify correlates of protective immunity
-
Deborah Burnett
Robogut-based animal-free evaluation of live biotherapeutic products active against carbapenem-resistant Enterobacteriaceae
-
Robert Mitchell
A predictive multi-omic trio of bladder transcriptomics, urinary metabolomics, and the gut microbiome for chronic urinary tract infection
-
Theresa TH Nguyen
Salmonella
multimutants identify SPI-2 T3SS effectors that contribute to gut inflammation, systemic infection, and pathogen transmission
in vivo
-
Joshua P. M. Newson